| Acne |
0 |
0.87 |
| Food and Drug Administration (FDA) |
0 |
0.87 |
| Pregnancy |
0 |
0.64 |
| Rosacea |
0 |
0.44 |
| Isotretinoin |
0 |
0.43 |
| Skin and Soft Tissue Infection |
0 |
0.14 |
| Revenue and Practice Management |
0 |
0.12 |
| Patient Safety |
0 |
0.11 |
| California |
0 |
0.09 |
| Hand |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| New York |
0 |
0.09 |
| Risk Evaluation and Mitigation Strategies |
0 |
0.09 |
| Social Media |
0 |
0.09 |
| Transgender |
0 |
0.09 |
| Washington |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.07 |